Defence

Sawtooth Solutions LLC buys 151 shares of Stryker Co. (NYSE:SYK)


Sawtooth Solutions LLC grew its stake in shares of Stryker Co. (NYSE: SYKGet a rating) by 9.2% during the second quarter, according to the company’s most recent 13F filing with the SEC. The firm owned 1,785 shares of the medical technology company’s stock after buying an additional 151 shares during the quarter. Sawtooth Solutions LLC’s holdings in Stryker were worth $355,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in SYK. TCI Wealth Advisors Inc. boosted its stake in Stryker by 8.1% in the second quarter. Now TCI Wealth Advisors Inc. now owns 1,004 shares of the medical technology company’s stock valued at $200,000 after buying an additional 75 shares in the last quarter. Legacy Wealth Asset Management LLC raised its stake in shares of Stryker by 2.5% during the 2nd quarter. Legacy Wealth Asset Management LLC now owns 5,650 shares of the medical technology company’s stock valued at $1,124,000 after acquiring an additional 139 shares during the period. Farmers Trust Co. grew its stake in shares of Stryker by 2.5% in the 2nd quarter. Now Farmers Trust Co. now owns 23,993 shares of the medical technology company’s stock valued at $4,773,000 after buying an additional 581 shares during the period. Keudell Morrison Wealth Management raised its stake in shares of Stryker by 3.2% in the 2nd quarter. Keudell Morrison Wealth Management now owns 5,176 shares of the medical technology company’s stock valued at $1,030,000 after buying an additional 162 shares during the period. Finally, Brown Miller Wealth Management LLC raised its stake in Stryker by 6.7% during the second quarter. Brown Miller Wealth Management LLC now owns 5,662 shares of the medical technology company’s stock worth $1,126,000 after buying an additional 358 shares in the last quarter. Currently, 76.44% of the shares are owned by institutional investors.

Stryker stock performance

Actions SYK opened at $202.54 on Friday. Stryker Co. has a 12 month low of $188.84 and a 12 month high of $280.43. The fifty day moving average is $213.96 and the 200 day moving average is $226.27. The company has a current ratio of 2.00, a gearing ratio of 1.15, and a debt-to-equity ratio of 0.85. The firm has a market cap of $76.59 billion, a PE ratio of 37.30, a P/E/G ratio of 2.45 and a beta of 1.03.

Striker (NYSE: SYKGet a rating) last issued its quarterly earnings data on Tuesday, July 26th. The medical technology company reported $2.25 EPS for the quarter, missing the consensus estimate of $2.27 by ($0.02). Stryker had a net margin of 11.79% and a return on equity of 23.34%. The company had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.53 billion. Earnings per share were $2.25 in the same quarter last year. Equities research analysts predict that Stryker Co. will post 9.38 EPS in the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, October 31st. Investors of record on Friday, September 30th will be paid a $0.695 dividend. This is $2.78 in annualized dividends and a dividend yield of 1.37%. The ex-dividend date is Thursday, September 29. Striker’s payout ratio is 51.20%.

A Wall Street analyst weighs in

SYK has been the subject of a number of analyst reports. Piper Sandler upped their target price on Stryker from $250.00 to $260.00 and gave the stock an “overweight” rating in a report on Wednesday, September 14th. Stifel Nicolaus cut their price target on Stryker from $285.00 to $245.00 in a report on Monday, July 18th. BTIG Research cut their price objective on Stryker from $244.00 to $238.00 and set a “buy” rating for the company in a report on Tuesday, September 6th. Edward Jones upgraded Stryker from a “hold” rating to a “buy” rating in a report on Thursday, July 28th. Finally, Morgan Stanley cut their price objective on Stryker from $270.00 to $220.00 and set an “equal weight” rating for the company in a report on Friday, July 15th. Five analysts have rated the stock with a hold rating and ten have assigned a “buy” rating to the stock. The stock presently has an average rating of “Moderate Buy” and an average target price of $256.29, according to MarketBeat.com.

Stryker Company Profile

(Get a rating)

Stryker Corporation operates as a medical technology company. The company operates in two segments: MedSurg and Neurotechnology and Orthopedics and Spine. The Orthopedics and Spine segment provides implants for use in hip and knee replacement, as well as extremity trauma and surgery. This segment also offers spinal implants, which include cervical, thoracolumbar, and interbody systems used in spinal injuries, deformities, and degenerative treatments.

Read more

Want to see what other hedge funds hold SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE: SYKGet a rating).

Institutional Ownership of Stryker (NYSE:SYK) by Quarter



Get news and ratings for Stryker Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Stryker and related companies MarketBeat.com’s FREE Daily E-Newsletter.

https://www.defenseworld.net/2022/10/01/sawtooth-solutions-llc-buys-151-shares-of-stryker-co-nysesyk.html Sawtooth Solutions LLC buys 151 shares of Stryker Co. (NYSE:SYK)

Back to top button